Disease Markers: Mucin 5B Monoclonal Antibodies

Abstract

Two new monoclonal antibodies, including Mucin 5B antibodies which can be used as markers to study cancers as well as airway diseases

Full Description

Two new monoclonal antibodies against human mucin 5B (MUC5B) have been developed by University of California, Davis investigators.

Applications

• Markers to study cancer and airway diseases such as chronic obstructive pulmonary disease (COPD)

Features/Benefits

• Are made against the peptide sequence, not the carbohydrates, of mucin 5B
• Are made against the N-terminal and central regions of the mucin 5B protein
• Are specific to mucin 5B
• Do not cross-react with other species